S. Eva Singletary

Q: What Schools Are Affiliated With S. Eva Singletary

S. Eva Singletary is affiliated with the following schools: MD Anderson Cancer Center, Baylor College of Medicine, University of California, San Francisco, Clemson University, Harvard University

S. Eva Singletary's AcademicInfluence.com Rankings

S. Eva Singletary

Philosophy

#7735

World Rank

#10986

Historical Rank

#1649

USA Rank

Logic

#4859

World Rank

#6191

Historical Rank

#835

USA Rank

philosophy Degrees

Download Badge

Philosophy

S. Eva Singletary's Degrees

Doctorate Medicine Harvard University

Why Is S. Eva Singletary Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Sonja Eva Singletary was an American surgeon who specialized in the care of breast cancer. She was a faculty member at the University of Texas MD Anderson Cancer Center and a past president of the Society of Surgical Oncology.

(See a Problem?)

S. Eva Singletary's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Clinical course of breast cancer patients with complete pathologic primary tumor and axillary lymph node response to doxorubicin-based neoadjuvant chemotherapy. (1999) (1301)
Revision of the American Joint Committee on Cancer staging system for breast cancer. (2002) (1236)
Measurement of residual breast cancer burden to predict survival after neoadjuvant chemotherapy. (2007) (1171)
Significantly higher pathologic complete remission rate after neoadjuvant therapy with trastuzumab, paclitaxel, and epirubicin chemotherapy: results of a randomized trial in human epidermal growth factor receptor 2-positive operable breast cancer. (2005) (1123)
Complementary/alternative medicine use in a comprehensive cancer center and the implications for oncology. (2000) (1035)
Surgical margins in patients with early-stage breast cancer treated with breast conservation therapy. (2002) (614)
Breast Cancer Staging: Working With the Sixth Edition of the AJCC Cancer Staging Manual (2006) (417)
Locoregional recurrence patterns after mastectomy and doxorubicin-based chemotherapy: implications for postoperative irradiation. (2000) (374)
Outcome after pathologic complete eradication of cytologically proven breast cancer axillary node metastases following primary chemotherapy. (2005) (369)
Incidence, time course, and determinants of menstrual bleeding after breast cancer treatment: a prospective study. (2006) (361)
Rating the Risk Factors for Breast Cancer (2003) (349)
Incidence and impact of documented eradication of breast cancer axillary lymph node metastases before surgery in patients treated with neoadjuvant chemotherapy. (1999) (348)
Role of ultrasound‐guided fine‐needle aspiration of indeterminate and suspicious axillary lymph nodes in the initial staging of breast carcinoma (2002) (345)
Breast cancer on the world wide web: cross sectional survey of quality of information and popularity of websites (2002) (327)
Local recurrence risk after skin-sparing and conventional mastectomy: a 6-year follow-up. (1999) (311)
Management of breast cancer during pregnancy using a standardized protocol. (1999) (306)
The Incidence of Occult Nipple-Areola Complex Involvement in Breast Cancer Patients Receiving a Skin-Sparing Mastectomy (1999) (302)
Predictors of invasive breast cancer in patients with an initial diagnosis of ductal carcinoma in situ: a guide to selective use of sentinel lymph node biopsy in management of ductal carcinoma in situ. (2005) (295)
Standard for Breast Conservation Therapy in the Management of Invasive Breast Carcinoma (2002) (295)
Breast conservation after neoadjuvant chemotherapy: the MD Anderson cancer center experience. (2004) (295)
Staging system for breast cancer: revisions for the 6th edition of the AJCC Cancer Staging Manual. (2003) (291)
Sentinel lymph node biopsy is accurate after neoadjuvant chemotherapy for breast cancer. (2000) (284)
Clinicopathologic Factors Predicting Involvement of Nonsentinel Axillary Nodes in Women With Breast Cancer (2003) (276)
Career Satisfaction, Practice Patterns and Burnout among Surgical Oncologists: Report on the Quality of Life of Members of the Society of Surgical Oncology (2007) (275)
Prognostic Factors in Node-Negative Breast Cancer: A Review of Studies With Sample Size More Than 200 and Follow-Up More Than 5 Years (2002) (266)
Role for Intraoperative Margin Assessment in Patients Undergoing Breast-Conserving Surgery (2007) (262)
Effect of Primary Tumor Extirpation in Breast Cancer Patients Who Present With Stage IV Disease and an Intact Primary Tumor (2006) (247)
Prospective evaluation of paclitaxel versus combination chemotherapy with fluorouracil, doxorubicin, and cyclophosphamide as neoadjuvant therapy in patients with operable breast cancer. (1999) (247)
Accuracy of Physical Examination, Ultrasonography, and Mammography in Predicting Residual Pathologic Tumor Size in Patients Treated With Neoadjuvant Chemotherapy (2006) (244)
Classifying local disease recurrences after breast conservation therapy based on location and histology (2002) (243)
Patterns of relapse in 1001 consecutive patients with melanoma nodal metastases. (1989) (237)
Positron emission tomography with fluorine‐18‐deoxyglucose in the detection and staging of breast cancer (1993) (234)
Elevated protein kinase C expression in human breast tumor biopsies relative to normal breast tissue. (1989) (225)
Feasibility of breast‐conservation surgery after induction chemotherapy for locally advanced breast carcinoma (1992) (219)
Radiofrequency ablation of solid tumors. (2001) (207)
Positive surgical margins and ipsilateral breast tumor recurrence predict disease‐specific survival after breast‐conserving therapy (2003) (205)
Small (< or = 2-cm) breast cancer treated with US-guided radiofrequency ablation: feasibility study. (2004) (204)
Long-term complications associated with breast-conservation surgery and radiotherapy (2002) (199)
Presentation, treatment, and outcome of local recurrence after skin-sparing mastectomy and immediate breast reconstruction (2006) (198)
Anaphylactic reactions to isosulfan blue dye during sentinel lymph node biopsy for breast cancer. (2001) (187)
Long-term results of combined-modality therapy for locally advanced breast cancer with ipsilateral supraclavicular metastases: The University of Texas M.D. Anderson Cancer Center experience. (2001) (185)
Predictors of local-regional recurrence after neoadjuvant chemotherapy and mastectomy without radiation. (2002) (185)
The oncologic risks of skin preservation at mastectomy when combined with immediate reconstruction of the breast. (1991) (178)
Evaluation of paclitaxel in adjuvant chemotherapy for patients with operable breast cancer: preliminary data of a prospective randomized trial. (2002) (175)
The influence of pathologic tumor characteristics on locoregional recurrence rates following mastectomy. (2001) (175)
The Free Transverse Rectus Abdominis Musculocutaneous Flap for Breast Reconstruction: One Center's Experience with 211 Consecutive Cases (1994) (173)
Randomized trial of high-dose chemotherapy and blood cell autografts for high-risk primary breast carcinoma. (2000) (169)
Metastases to the breast from nonbreast solid neoplasms (2007) (163)
A role for curative surgery in the treatment of selected patients with metastatic breast cancer. (2003) (159)
Classification of isolated tumor cells (2003) (155)
The use of alternate, non-cross-resistant adjuvant chemotherapy on the basis of pathologic response to a neoadjuvant doxorubicin-based regimen in women with operable breast cancer: long-term results from a prospective randomized trial. (2004) (150)
Biological effect of epidermal growth factor on the in vitro growth of human tumors. (1987) (149)
Breast conservation after neoadjuvant chemotherapy (2005) (149)
Surgical decision making and factors determining a diagnosis of breast carcinoma in women presenting with nipple discharge. (2003) (148)
Residual metastatic axillary lymph nodes following neoadjuvant chemotherapy predict disease-free survival in patients with locally advanced breast cancer. (1998) (148)
Treatment and outcome of patients with intracystic papillary carcinoma of the breast. (2002) (145)
Impact of Preoperative Versus Postoperative Chemotherapy on the Extent and Number of Surgical Procedures in Patients Treated in Randomized Clinical Trials for Breast Cancer (2006) (144)
Revision of breast cancer staging: the 6th edition of the TNM Classification. (2003) (144)
Validation of a Breast Cancer Nomogram for Predicting Nonsentinel Lymph Node Metastases After a Positive Sentinel Node Biopsy (2006) (144)
Combined modality treatment of stage III and inflammatory breast cancer. M.D. Anderson Cancer Center experience. (1995) (143)
Changes in the 2003 American Joint Committee on Cancer staging for breast cancer dramatically affect stage-specific survival. (2003) (143)
Inflammatory breast cancer (IBC) and patterns of recurrence (2007) (142)
Standard for the Management of Ductal Carcinoma In Situ of the Breast (DCIS) (2002) (140)
Overexpression of both p185c-erbB2 and p170mdr-1 renders breast cancer cells highly resistant to taxol (1998) (135)
Incidence and time course of bleeding after long‐term amenorrhea after breast cancer treatment (2010) (134)
The effect of ethnicity on immediate reconstruction rates after mastectomy for breast cancer (2004) (130)
Intraoperative margin assessment reduces reexcision rates in patients with ductal carcinoma in situ treated with breast-conserving surgery. (2003) (128)
Feasibility of Immediate Breast Reconstruction for Locally Advanced Breast Cancer (1999) (125)
Impact of Clinicopathological Factors on Sensitivity of Axillary Ultrasonography in the Detection of Axillary Nodal Metastases in Patients With Breast Cancer (2003) (125)
Locoregional treatment outcomes after multimodality management of inflammatory breast cancer. (2008) (121)
Trends for inflammatory breast cancer: is survival improving? (2007) (120)
Mammography before diagnosis among women age 80 years and older with breast cancer. (2008) (118)
Coping, life attitudes, and immune responses to imagery and group support after breast cancer treatment. (1997) (116)
Predictors of locoregional recurrence among patients with early-stage breast cancer treated with breast-conserving therapy (2007) (116)
Feasibility of Breast Preservation in the Treatment of Occult Primary Carcinoma Presenting With Axillary Metastases (2001) (115)
Reduced DNA repair of benzo[a]pyrene diol epoxide-induced adducts and common XPD polymorphisms in breast cancer patients. (2004) (111)
Impact of systemic treatment on local control for patients with lymph node-negative breast cancer treated with breast-conservation therapy. (2001) (108)
Improving local control with breast‐conserving therapy (2005) (105)
Estrogen replacement therapy after localized breast cancer: clinical outcome of 319 women followed prospectively. (1999) (104)
Multidisciplinary management of breast cancer concurrent with pregnancy. (2002) (98)
The Nuclear Transcription Factor κB/bcl-2 Pathway Correlates with Pathologic Complete Response to Doxorubicin-Based Neoadjuvant Chemotherapy in Human Breast Cancer (2005) (97)
Stereotactic core‐needle biopsy of the breast: A report of the Joint Task Force of the American College of Radiology, American College of Surgeons, and College of American Pathologists (1997) (95)
Detection of 2-amino-1-methyl-6-phenylimidazo[4,5-b]-pyridine-DNA adducts in normal breast tissues and risk of breast cancer. (2003) (95)
Surgical conservation planning after neoadjuvant chemotherapy for stage II and operable stage III breast carcinoma. (2001) (95)
Incidence of anaphylactoid reactions to isosulfan blue dye during breast carcinoma lymphatic mapping in patients treated with preoperative prophylaxis (2005) (94)
MANAGEMENT OF BREAST CANCER DURING PREGNANCY USING A STANDARDIZED PROTOCOL (1999) (93)
Pathologic tumor size and lymph node status predict for different rates of locoregional recurrence after mastectomy for breast cancer patients treated with neoadjuvant versus adjuvant chemotherapy. (2002) (92)
Accuracy of the Combination of Mammography and Sonography in Predicting Tumor Response in Breast Cancer Patients After Neoadjuvant Chemotherapy (2006) (91)
Reduction Mammaplasty: Its Role in Breast Conservation Surgery for Early‐Stage Breast Cancer (1998) (91)
Incidence and Prevention of Venous Thromboembolism in Patients Undergoing Breast Cancer Surgery and Treated According to Clinical Pathways (2006) (90)
A prospective trial of preoperative chemotherapy in resectable breast cancer: Predictors of breast-conservation therapy feasibility (2002) (89)
Treatment Trends in Early-Stage Invasive Lobular Carcinoma: A Report From the National Cancer Data Base (2005) (87)
Clinical decision-making in early breast cancer. (1993) (86)
Contralateral prophylactic mastectomy (2004) (85)
Presentation, management and outcome of axillary recurrence from breast cancer. (2000) (84)
Sensitivity to benzo(a)pyrene diol-epoxide associated with risk of breast cancer in young women and modulation by glutathione S-transferase polymorphisms: a case-control study. (2001) (82)
Reduction mammoplasty improves breast conservation therapy in patients with macromastia. (2001) (81)
Skin-sparing mastectomy with immediate breast reconstruction: The M. D. Anderson cancer center experience (1996) (80)
A case–control study of unilateral and bilateral breast carcinoma patients (2001) (80)
Pathologic tumor response in the breast following neoadjuvant chemotherapy predicts axillary lymph node status. (1998) (78)
Recursive partitioning analysis of locoregional recurrence patterns following mastectomy: implications for adjuvant irradiation. (2001) (78)
Feasibility of postmastectomy radiation therapy after TRAM flap breast reconstruction (2006) (77)
Selective use of sentinel lymph node surgery during prophylactic mastectomy (2006) (77)
Radiofrequency ablation of early-stage invasive breast tumors: an overview. (2002) (77)
Locoregional irradiation for inflammatory breast cancer: effectiveness of dose escalation in decreasing recurrence. (2000) (76)
Impact of multicentricity on clinical outcome in patients with T1-2, N0-1, M0 breast cancer (2007) (75)
Paget’s Disease of the Breast: There Is a Role for Breast-Conserving Therapy (2005) (74)
Chest Wall Recurrence After Mastectomy Does Not Always Portend a Dismal Outcome (2003) (72)
Clinical outcome of patients with lymph node‐negative breast carcinoma who have sentinel lymph node micrometastases detected by immunohistochemistry (2005) (72)
Polymorphisms and haplotypes of the NBS1 gene are associated with risk of sporadic breast cancer in non-Hispanic white women <or=55 years. (2006) (69)
T3 disease at presentation or pathologic involvement of four or more lymph nodes predict for locoregional recurrence in stage II breast cancer treated with neoadjuvant chemotherapy and mastectomy without radiotherapy. (2004) (68)
Tubular carcinoma of the breast. Predicting axillary nodal metastases and recurrence. (1996) (68)
Recruitment for complementary/alternative medicine trials: WHO participates after breast cancer (1998) (67)
Effect of Dietary Intake of Phytoestrogens on Estrogen Receptor Status in Premenopausal Women With Breast Cancer (2005) (66)
Clinical course of patients with breast cancer with ten or more positive nodes who were treated with doxorubicin‐containing adjuvant therapy (1992) (66)
The effect of under-treatment of breast cancer in women 80 years of age and older. (2011) (65)
Disease‐free and overall survival after pathologic complete disease remission of cytologically proven inflammatory breast carcinoma axillary lymph node metastases after primary systemic chemotherapy (2006) (64)
Oncologic Safety of Skin-Sparing Mastectomy (2003) (64)
Multimodal treatment for inflammatory breast cancer. (1989) (62)
Mentoring Surgeons for the 21st Century (2005) (61)
The feasibility of minimally invasive surgery for Stage IIA, IIB, and IIIA breast carcinoma patients after tumor downstaging with induction chemotherapy (2000) (61)
Current results of treatment for distant metastatic well-differentiated thyroid carcinoma. (1989) (61)
Locoregional treatment outcomes for inoperable anthracycline-resistant breast cancer. (2002) (61)
Risk of recurrence after treatment of early breast cancer with skin-sparing mastectomy (1997) (60)
Neoadjuvant chemotherapy in women with invasive breast carcinoma: conceptual basis and fundamental surgical issues. (2000) (60)
US-guided implantation of metallic markers for permanent localization of the tumor bed in patients with breast cancer who undergo preoperative chemotherapy. (1999) (59)
Advanced Therapy of Breast Disease (1999) (59)
Evaluation of Lymph Node Status in Male Breast Cancer Patients: A Role for Sentinel Lymph Node Biopsy* (2004) (58)
Prognostic factors in patients with regional cervical nodal metastases from cutaneous malignant melanoma. (1986) (57)
DOC-2/hDab-2 inhibits ILK activity and induces anoikis in breast cancer cells through an Akt-independent pathway (2001) (56)
Defining the clinical diagnosis of inflammatory breast cancer. (2008) (55)
Current comprehensive assessment and management of women at increased risk for breast cancer. (2004) (54)
Localization of impalpable breast masses: value of sonography in the operating room and scanning of excised specimens. (1994) (53)
Locally advanced noninflammatory breast cancer. (1996) (51)
The safety of breast‐conserving surgery in patients who achieve a complete pathologic response after neoadjuvant chemotherapy (2006) (51)
Adverse prognostic significance of infraclavicular lymph nodes detected by ultrasonography in patients with locally advanced breast cancer. (2001) (49)
Physician recommendations regarding tamoxifen and patient utilization of tamoxifen after surgery for ductal carcinoma in situ (2004) (49)
Minimally invasive techniques in breast cancer treatment. (2001) (49)
Establishment of a New Human Pancreatic Adenocarcinoma Cell Line, MDAPanc‐3 (1990) (48)
Lymphatic Drainage Patterns on Early Versus Delayed Breast Lymphoscintigraphy Performed after Injection of Filtered Tc-99m Sulfur Colloid in Breast Cancer Patients Undergoing Sentinel Lymph Node Biopsy (2005) (48)
Feasibility of radiofrequency ablation for primary breast cancer (2003) (48)
Occurrence and prognosis of contralateral carcinoma of the breast. (1994) (48)
Utility of Breast Sentinel Lymph Node Biopsy Using Day-Before-Surgery Injection of High-Dose 99mTc-Labeled Sulfur Colloid (2001) (48)
The correlation of axillary ultrasonography with histologic breast cancer downstaging after induction chemotherapy. (2000) (48)
Prospective, randomized, double-blind study of prophylactic antibiotics in axillary lymph node dissection. (1998) (48)
Nipple aspirate fluid cytology in breast carcinoma (2002) (47)
Effective Local Control and Long-Term Survival in Patients with T4 Locally Advanced Breast Cancer Treated with Breast Conservation Therapy (2004) (46)
Repair of partial mastectomy defects. (1998) (46)
Predictors of systemic recurrence and disease‐specific survival after ipsilateral breast tumor recurrence (2005) (46)
Breast cancer vaccines (2007) (45)
Breast cancer in the elderly. (1993) (45)
Indium-111-labeled B72.3 monoclonal antibody in the detection and staging of breast cancer: a phase I study. (1991) (45)
Anaphylactoid reactions to isosulfan blue dye during breast cancer lymphatic mapping in patients given preoperative prophylaxis. (2004) (45)
Use of lymphoscintigraphy defines lymphatic drainage patterns before sentinel lymph node biopsy for breast cancer. (2006) (44)
Role of axillary lymph node dissection after tumor downstaging with induction chemotherapy for locally advanced breast cancer (1998) (44)
Effects of race and socioeconomic status on survival of 1,332 black, hispanic, and white women with breast cancer (1997) (44)
Sequencing of chemotherapy and radiation in lymph node-negative breast cancer. (1999) (43)
Estrogen replacement therapy for menopausal women with a history of breast carcinoma (2002) (43)
Fine‐needle aspiration cytology of the male breast in a cancer center (1993) (42)
Multimodality treatment for inflammatory breast cancer. (1990) (42)
Phase II clinical trial of N-(4-Hydroxyphenyl)retinamide and tamoxifen administration before definitive surgery for breast neoplasia. (2002) (42)
Expressive writing as a presurgical stress management intervention for breast cancer patients. (2008) (41)
Factors predictive of outcome in patients with breast cancer refractory to neoadjuvant chemotherapy. (2001) (39)
Primary chemotherapy for early and advanced breast cancer. (1995) (39)
Combined modality treatment of locally advanced breast carcinoma in elderly patients or patients with severe comorbid conditions using tamoxifen as the primary therapy (2000) (39)
Surgical management of inflammatory breast cancer. (2008) (39)
Radiofrequency Ablation of Breast Cancer (2003) (38)
Practice guideline for the breast conservation therapy in the management of invasive breast carcinoma. (2007) (38)
Adjuvant therapy with escalating doses of doxorubicin and cyclophosphamide with or without leukocyte alpha-interferon for stage II or III breast cancer. (1992) (38)
Surgical management of groin nodal metastases from primary melanoma of the lower extremity. (1992) (37)
Primary Tumor Response to Induction Chemotherapy as a Predictor of Histological Status of Axillary Nodes in Operable Breast Cancer Patients (1999) (36)
Genetic and environmental determinants on tissue response to in vitro carcinogen exposure and risk of breast cancer. (2002) (35)
Neoadjuvant chemotherapy in the treatment of stage II and III breast cancer. (2001) (34)
High and differential expression of HER-2/neu extracellular domain in bilateral ductal fluids from women with unilateral invasive breast cancer. (2003) (34)
Postmastectomy radiotherapy. American College of Radiology. ACR Appropriateness Criteria. (2000) (33)
Local-regional control of recurrent breast carcinoma after mastectomy: does hyperfractionated accelerated radiotherapy improve local control? (1999) (33)
Comparison between clinical response and in vitro drug sensitivity of primary human tumors in the adhesive tumor cell culture system. (1987) (33)
Randomized trial of high‐dose chemotherapy and autologous hematopoietic stem cell support for high‐risk primary breast carcinoma (2006) (32)
Treatment and outcome of patients with chest wall recurrence after mastectomy and breast reconstruction. (2004) (32)
Feasibility of Breast Conservation Therapy in Metachronous or Synchronous Bilateral Breast Cancer (1999) (32)
Breast cancer in adolescent females. (1995) (31)
Local Recurrence and Survival Among Black Women With Early-Stage Breast Cancer Treated With Breast-Conservation Therapy or Mastectomy (1999) (31)
New approaches to surgery for breast cancer. (2001) (31)
Role of conservation therapy for invasive lobular carcinoma of the breast (2006) (31)
Masses in breasts with implants: diagnosis with US-guided fine-needle aspiration biopsy. (1994) (29)
Changes in female support network systems and adaptation after breast cancer diagnosis: differences between older and younger patients. (2009) (29)
Skin-sparing mastectomy with immediate breast reconstruction. (2000) (28)
Collective reviewProphylactic mastectomy (2000) (27)
Prognostic Implications of Pathological Lymph Node Status After Preoperative Chemotherapy for Operable T3N0M0 Breast Cancer (2000) (27)
Image-guided surgery of small breast cancers. (2001) (27)
Surgical Management of Primary Lymphoma of the Breast (1991) (26)
Positron Emission Tomography of Glucose Metabolism in Breast Cancer (1993) (26)
Dietary Intake of Selected Fatty Acids, Cholesterol and Carotenoids and Estrogen Receptor Status in Premenopausal Breast Cancer Patients (2002) (25)
Genetic variants in the H2AFX promoter region are associated with risk of sporadic breast cancer in non-Hispanic white women aged ≤55 years (2008) (25)
Systemic treatment after sentinel lymph node biopsy in breast cancer: who, what, and why? (2001) (25)
Impact of concurrent proliferative high‐risk lesions on the risk of ipsilateral breast carcinoma recurrence and contralateral breast carcinoma development in patients with ductal carcinoma in situ treated with breast‐conserving therapy (2006) (25)
Feasibility of breast‐conserving surgery for patients with breast carcinoma associated with nipple discharge (2004) (24)
A review of technical aspects of sentinel lymph node identification for breast cancer. (2002) (23)
Axillary lymph node cellular immune response to HER-2/neu peptides in patients with carcinoma of the breast. (2002) (23)
Decision analysis to assess the efficacy of routine sentinel lymphadenectomy in patients undergoing prophylactic mastectomy (2007) (23)
A working model for the time sequence of genetic changes in breast tumorigenesis. (2002) (22)
Prospective randomized trial of paclitaxel alone versus 5-fluorouracil/doxorubicin/cyclophosphamide as induction therapy in patients with operable breast cancer. (1997) (22)
Management of inflammatory breast cancer (2004) (22)
The human tumor stem cell assay revisited. (1985) (21)
Synchronous elective contralateral mastectomy and immediate bilateral breast reconstruction in women with early-stage breast cancer (1998) (21)
Biologic basis and evolving role of aromatase inhibitors in the management of invasive carcinoma of the breast (2001) (20)
Melanoma With Metastasis to Regional Axillary or Inguinal Lymph Nodes: Prognostic Factors and Results of Surgical Treatment in 714 Patients (1988) (19)
The effect of undertreatment of breast cancer in women 80 years of age and older (2011) (19)
Scientific paper Surgical margins in patients with early-stage breast cancer treated with breast conservation therapy (2002) (19)
Use of aromatase inhibitors in postmenopausal women with advanced breast cancer (1997) (19)
Improving residents' clinical skills with the structured clinical instruction module for breast cancer: results of a multiinstitutional study. Breast Cancer Education Working Group. (1997) (18)
The Role of Contralateral Prophylactic Mastectomy in Invasive Lobular Carcinoma (1997) (18)
Local rotational flaps for breast conservation therapy as an alternative to mastectomy (1997) (18)
Unusual aspects of breast cancer: case 3. Blue hives during lymphatic mapping for breast cancer. (2001) (17)
Expression of ERα and ERβ in lobular carcinoma in situ (2007) (17)
Reconstructive Management of Contralateral Breast Cancer in Patients Who Previously Underwent Unilateral Breast Reconstruction (2001) (17)
Breast-conservation therapy in early-stage breast cancer patients with a positive family history (2002) (16)
Aggressive therapy for locoregional recurrence after mastectomy in stage II and III breast cancer patients (2006) (15)
Patient satisfaction with 23-hour "short-stay" observation following breast cancer surgery. (1997) (15)
Determinants of mastectomy in breast conservation therapy candidates. (2005) (14)
Overview of adjuvant systemic therapy in early stage breast cancer. (2007) (14)
The multidisciplinary structured clinical instruction module as a vehicle for cancer education. (1997) (14)
Purging of contaminating breast cancer cells from hematopoietic stem cell grafts by adenoviral GAL-TEK gene therapy and magnetic antibody cell separation. (1999) (13)
Importance of radiation therapy for breast cancer patients treated with high-dose chemotherapy and stem cell transplant. (2000) (12)
Lobular carcinoma in situ of the breast; a 31-year experience at the university of Texas M. D. Anderson cancer center (1994) (12)
Fine-needle aspiration of the breast: diagnostic problems and approaches to surgical management. (1994) (12)
Intraarterial infusion chemotherapy in regionally advanced malignant melanoma (1990) (12)
Enhancement of growth of primary metastatic fresh human tumors of the nervous system by epidermal growth factor in serum-free short term culture. (1988) (12)
Dose-survival curves of cis-platinum, melphalan, and velban in human granulocyte/macrophage progenitor cells. (1984) (12)
Management of breast carcinoma identified intraoperatively during reduction mammaplasty. (2003) (11)
Effects and interactions of epidermal growth factor, insulin, hydrocortisone, and estradiol on the cloning of human tumor cells. (1985) (11)
Fifteen-year results of a randomized prospective trial of hyperfractionated chest wall irradiation versus once-daily chest wall irradiation after chemotherapy and mastectomy for patients with locally advanced noninflammatory breast cancer. (2006) (11)
Conservative surgery and radiation in the treatment of stage I and II carcinoma of the breast. American College of Radiology. ACR Appropriateness Criteria. (2000) (11)
Minimally invasive surgery in breast cancer treatment. (2001) (11)
Does Breast Conservation Therapy in Young Women with Breast Cancer Adversely Affect Local Disease Control and Survival Rate? The M. D. Anderson Cancer Center Experience (1997) (11)
Multidisciplinary frontiers in breast cancer management (2007) (10)
The need for breast cancer screening in women undergoing elective breast surgery: an assessment of risk and risk factors for breast cancer in young women. (2010) (9)
Minimally invasive operation for breast cancer. (2004) (9)
Breast cancer management: The road to today (2008) (8)
Segmental mastectomy and irradiation in the treatment of breast cancer. (1988) (8)
Transforming growth factor-alpha secretion by epidermal growth factor-dependent human tumor cell lines. (1990) (7)
Clinically occult breast carcinoma: Diagnostic approaches and role of axillary node dissection (1995) (7)
Ductal carcinoma in situ of the breast: comedo versus noncomedo subtype mnonpredictive of recurrence or contralateral new breast primary (1994) (7)
A Fire in Our Hearts: Passion and the Art of Surgery (2010) (7)
Surgical and medical management of local-regional treatment failures in advanced primary breast cancer. (1995) (7)
Minimally invasive ablation techniques in breast cancer treatment (2002) (7)
New strategies in locally advanced breast cancer. (1997) (6)
Satisfaction of breast cancer patients with a nonphysician-provider model of long-term follow-up care (1996) (6)
Integration of neoadjuvant chemotherapy and surgery in the treatment of patients with breast carcinoma. (2001) (6)
Local-regional control in breast cancer patients with a possible genetic predisposition. (2000) (6)
Factors influencing management of breast cancer in the elderly woman. (1993) (6)
Special considerations in breast cancer risk and survival (1999) (6)
Prophylactic mastectomy. (2000) (5)
Epidermal growth factor effect on serum-free growth of primary and metastatic human tumors. (1989) (5)
Educational Review: Role of the Surgeon in Hereditary Breast Cancer (2001) (5)
Bivariate RNA and DNA content analysis in breast carcinoma: biological significance of RNA content. (1996) (5)
Ductal carcinoma in situ and microinvasive disease. American College of Radiology. ACR Appropriateness Criteria. (2000) (4)
Current Treatment Options for Inflammatory Breast Cancer (1999) (4)
Magnetic resonance imaging, positron emission tomography, and radioimmunoscintigraphy of breast cancer (1993) (4)
What comes next? Building a new life after retirement from surgery. (2010) (4)
Twelve-year follow-up of a randomized trial of high-dose chemotherapy (HDC) and autologous hematopoietic stem cell support (ASCS) for high-risk primary breast carcinoma (2005) (4)
Breast cancer surgery for the 21st century: the continuing evolution of minimally invasive treatments. (2006) (4)
Applications of radiofrequency ablation in the treatment of breast cancer (2005) (4)
Primary chemotherapy for breast cancer — MD Anderson experience (1991) (4)
Locally advanced breast cancer. American College of Radiology. ACR Appropriateness Criteria. (2000) (3)
The clinical impact of proliferative high-risk lesions presenting concurrently with ductal carcinoma in situ (DCIS) in patients (pts) treated with breast conserving therapy (BCT) (2005) (3)
Surveillance Studies and Long-Term Follow-Up Care (1999) (3)
Educational Review Hormone Replacement Therapy and Breast Cancer (1999) (3)
Phyllodes tumors of the breast (1995) (3)
Flow cytometric analysis of Ki-67 in invasive ductal carcinoma of the breast: correlation with tumor and patient characteristics. (1999) (3)
Adjuvant therapy for node-negative breast cancer patients. Who benefits? (1988) (3)
Breast Cancer (2002) (3)
Isolated tumor cells in bone marrow of early-stage breast cancer patients. (2006) (3)
Predictors of invasive breast cancer in patients with an initial diagnosis of ductal carcinoma in situ: A guide to the selective carcinoma in situ (2004) (2)
Long-term outcome of patients with complete eradication of cytologically proven axillary node metastases after primary chemotherapy: The University of Texas M. D. Anderson Cancer Center experience (2004) (2)
New clinical trends in the adjuvant therapy of early stage breast cancer. (1998) (2)
Inflammatory Breast Cancer (1999) (2)
Long term survival after an aggressive surgical approach in patients with breast cancer hepatic metastases (2006) (1)
Nijmegen breakage syndrome 1 (NBS1) gene polymorphism and chemotherapy-induced neutropenic fever in breast cancer patients (2007) (1)
Endocrine-Related Cancer ( 2001 ) 8 265 – 286 New approaches to surgery for breast cancer (2001) (1)
Primary chemotherapy for breast cancer : response to preoperative chemotherapy as prognostic factor (1994) (1)
Long-term efficacy and late sequelae of Doxorubicin containing adjuvant therapy for breast cancer : MD Anderson Cancer Center studies (1994) (1)
Should surgical recertification reflect subspecialization? (2008) (1)
Locoregional R ecurrence P atterns A fter M astectomy a nd Doxorubicin-Base d C hemotherapy: I mplications f or Postoperative I rradiation (2000) (1)
Intramammary lymph node metastases are an independent predictor in breast cancer outcomes (2004) (1)
Hormone replacement therapy and breast cancer. (1999) (1)
Local regional recurrence and salvage surgery. American College of Radiology. ACR Appropriateness Criteria. (2000) (1)
Estrogen R eplacement T herapy A fter L ocalized B reast Cancer: C linical O utcome o f 3 19 W omen Followed P rospectively (2006) (0)
Intramammary lymph node metastases are an independent predictor in breast cancer outcomes. (2004) (0)
Society of Surgical Oncology Heritage Award: Honoring Edward M. Copeland III, MD, FACS (2007) (0)
Hyperthermia potentiation of adriamycin adr and cisplatinum cddp in the primary human adhesive tumor cell culture system atccs (1988) (0)
Complementary/Al ternative M edicine U se i n a Comprehensive C ancer C enter a nd t he I mplications for O ncology (2000) (0)
Prognostic factors in patients with regional cervical nodal metastases from cutaneous malignant melanoma (1987) (0)
Percutaneous ablation of breast tumors: Towards an era of surgery without scalpels (2002) (0)
Diabetic mastopathy : A masquerader of breast cancer : A report of two cases (1996) (0)
Phase II Clinical Trial of N-( 4-Hydroxyphenyl ) retinamide and Tamoxifen Administration before Definitive Surgery for Breast Neoplasia 1 (2002) (0)
Radiotherapy for early stage favourable breast cancers (2002) (0)
Revision o f t he A merican J oint C ommittee o n C ancer Staging S ystem f or B reast C ancer (2011) (0)
Prognostic Factors in Node-Negative Breast Cancer (2001) (0)
Changes i n t he 2 003 A merican J oint C ommittee o n C ancer Staging f or B reast C ancer D ramatically A ffect S tage-Specific Survival (2003) (0)
Contralateral prophylactic mastectomy: Efficacy and determinants of significant histologic findings (2004) (0)
A woman's decision: Breast care, treatment & reconstruction, 2nd edition (1994) (0)
Symposium overview: Estrogens and antiestrogens in managing the patient with breast cancer (2007) (0)
LCIS: Is tamoxifen a rational chemoprevention choice? (2005) (0)
Premenopausal breast cancer and the association between estrogen receptor status, insulin-like growth factor-I (IGF-I), insulin-like growth factor binding protein-3 (IGFBP-3) and leptin. (2006) (0)
Impact on overall survival of primary tumor extirpation in breast cancer patients who present with stage IV disease (2007) (0)
Locally advanced breast cancer: integration of multimodal concepts. (1995) (0)
Fifteen-year Results of a Randomized Prospective Trial Comparing Hyperfractionated Versus Once-Daily Chest Wall Radiation After Chemotherapy and Mastectomy for Patients with Locally Advanced Non-Inflammatory Breast Cancer (2005) (0)
Predictors o f L ocal-Regional R ecurrence A fter N eoadjuvant Chemotherapy a nd M astectomy W ithout R adiation (2002) (0)
Prospective E valuation o f P aclitaxel V ersus C ombination Chemotherapy W ith F luorouracil, D oxorubicin, and C yclophosphamide a s N eoadjuvant T herapy i n P atients With O perable B reast C ancer (1999) (0)
Long-term complications associated with breast-conservation surgery and radiotherapy. (2002) (0)
Candidates for Minimally Invasive Therapy of Breast Cancer: Redefining the Standards (2003) (0)
Introduction of Dr. Alfred M. Cohen (2004) (0)
POSITRON EMISSION TOMOGRAPHY (PET) OF BREAST CANCER USING 18F-FLUORODEOXYGLUCOSE (FDG) (1992) (0)
Author reply (0)
Breast conservation therapy in T4 locally advanced breast cancer: Effective local control with long-term survival (2004) (0)
Genetic and Environmental Determinants on Tissue Response to in Vitro Carcinogen Exposure and Risk of Breast Cancer 1 (2002) (0)
Sentinel L ymph N ode B iopsy I s A ccurate A fter N eoadjuvant Chemotherapy f or B reast C ancer (2000) (0)
Breast Diseases 2005 Annual (2004) (0)
Growth of Human Tumors in Vitro Biological Effect of Epidermal Growth Factor on the Updated (2006) (0)
Lymphatic mapping for male breast cancer (2001) (0)
DILEMMAS IN BREAST DISEASE (1996) (0)
Long-term outcome of patients with complete eradication of cytologically proven axillary node metastases after primary chemotherapy: The University of Texas M. D. Anderson Cancer Center experience. (2004) (0)
A step-by-step guide to breast self-examination. (2005) (0)
Breast cancer: new concepts in management (2003) (0)
2063 Predicting outcome in patients with locoregionally recurrent breast carcinoma after mastectomy (1999) (0)

This paper list is powered by the following services:

Other Resources About S. Eva Singletary

en.wikipedia.org

What Schools Are Affiliated With S. Eva Singletary?

S. Eva Singletary is affiliated with the following schools:

S. Eva Singletary's Academic­Influence.com Rankings